NASDAQ$IPGP
Ipg Photonics Corp. · Q2 2020 earnings
Q2 2020 earnings · · Investor relations
Briefing
IPG Photonics' second quarter results exceeded guidance due to strong performance in China and new products, despite challenges from the COVID-19 pandemic.
IPG Photonics reported a 19% year-over-year decrease in revenue to $296 million for Q2 2020, but exceeded their guidance range due to better-than-expected performance in China and strength in new products. EPS decreased 47% year over year to $0.71, which was reduced by $0.20 due to foreign exchange losses and restructuring charges. The company generated $73 million in cash from operations during the quarter.
- Second quarter revenue decreased 19% year over year to $296 million.
- Earnings per diluted share decreased 47% year over year to $0.71, reduced by $0.20 from foreign exchange loss and restructuring.
- Materials processing sales decreased 21% year over year, while sales into other applications increased 36% year over year.
- Sales decreased 11% in China, 24% in Europe, 16% in Japan and 16% in North America year over year.
Headline financials
Revenue & EPS history
IPG Photonics · Revenue · Quarterly
$296M
Revenue by segment
IPG Photonics · $296M total across 2 segments · Q2 2020
- Materials Processing$273M-21.1%92.0%
- Other Applications$23.7M+34.4%8.0%
Forward guidance
For the third quarter of 2020, IPG expects revenue of $280 million to $310 million and earnings per diluted share in the range of $0.70 to $1.00.
Tailwinds
- Near-term growth opportunities in ultra-high power cutting.
- Growth opportunities in electric vehicle battery processing.
- Growth opportunities in systems and devices for the medical industry.
- Strides in higher power products within our core materials processing business.
- New solutions will enable the company to emerge from the pandemic in a stronger competitive position.
Headwinds
- Visibility into a recovery in global demand remains uncertain.
- Financial guidance is subject to greater risk and uncertainty given the COVID-19 pandemic.
- Impacts to the global business environment.
- Impacts to public health requirements.
- Impacts to government mandates.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2020
-0.7%
Avg return
Earnings day
-0.9%
Avg return
5 days after
-2.3%
Avg return
30 days after
43%
28 / 65 earnings
Positive
+35.5%
Q4 2025
Best reaction
-26.2%
Q2 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -25.1% | -14.6% | +0.1% | |
| Q4 2025 | +35.5% | +21.6% | +0.0% | |
| Q3 2025 | -0.2% | -2.3% | -9.9% | |
| Q1 2025 | -13.0% | -4.7% | +8.4% | |
| Q4 2024 | -5.5% | -5.7% | -11.7% | |
| Q3 2024 | +5.1% | +3.8% | -2.5% | |
| Q2 2024 | -8.2% | -18.5% | -21.0% | |
| Q1 2024 | -5.7% | -2.1% | -3.9% | |
| Q4 2023 | -15.2% | -16.5% | -16.0% | |
| Q3 2023 | +4.0% | +9.8% | +14.4% | |
| Q2 2023 | -15.1% | -17.2% | -17.6% | |
| Q1 2023 | +0.7% | +0.2% | -6.4% | |
| Q4 2022 | +16.5% | +16.6% | +6.5% | |
| Q3 2022 | +2.6% | +2.5% | +8.3% | |
| Q2 2022 | -3.9% | -5.4% | -16.0% | |
| Q1 2022 | +10.7% | +1.9% | +5.9% | |
| Q4 2021 | -4.1% | -6.7% | -20.5% | |
| Q3 2021 | +7.6% | +5.0% | -0.5% | |
| Q2 2021 | -17.3% | -16.5% | -20.3% | |
| Q1 2021 | -10.4% | -6.7% | -5.0% | |
| Q4 2020 | -6.1% | -7.2% | -16.7% | |
| Q3 2020 | +1.9% | +3.6% | +8.8% | |
| Q2 2020 | -7.4% | -9.3% | -9.3% | |
| Q1 2020 | +21.1% | +27.7% | +35.5% | |
| Q4 2019 | -5.2% | -7.7% | -23.7% | |
| Q3 2019 | -7.1% | -2.9% | +0.7% | |
| Q2 2019 | -6.0% | -15.0% | -12.0% | |
| Q1 2019 | -1.3% | -0.9% | -25.7% | |
| Q4 2018 | +8.8% | +12.8% | +8.9% | |
| Q3 2018 | +1.7% | +11.0% | +7.6% | |
| Q2 2018 | -26.2% | -24.0% | -23.0% | |
| Q1 2018 | +6.3% | +9.5% | +13.3% | |
| Q4 2017 | -7.7% | -4.3% | -4.7% | |
| Q3 2017 | -0.6% | +3.0% | +10.3% | |
| Q2 2017 | +6.2% | +5.3% | +15.2% | |
| Q1 2017 | +6.9% | +5.6% | +11.1% | |
| Q4 2016 | +4.9% | +2.9% | +3.5% | |
| Q3 2016 | +14.2% | +12.2% | +14.8% | |
| Q2 2016 | +0.0% | -1.5% | +3.3% | |
| Q1 2016 | -15.6% | — | — | |
| Q4 2015 | -2.5% | — | — | |
| Q3 2015 | +11.7% | — | — | |
| Q2 2015 | +16.8% | — | — | |
| Q1 2015 | -2.2% | — | — | |
| Q4 2014 | +9.4% | — | — | |
| Q3 2014 | +5.9% | — | — | |
| Q2 2014 | +8.3% | — | — | |
| Q1 2014 | -5.2% | — | — | |
| Q4 2013 | +1.6% | — | — | |
| Q3 2013 | -9.1% | — | — | |
| Q2 2013 | -0.7% | — | — | |
| Q1 2013 | -9.1% | — | — | |
| Q1 2011 | +2.6% | — | — | |
| Q4 2012 | -10.6% | — | — | |
| Q3 2012 | -5.4% | — | — | |
| Q4 2011 | +10.5% | — | — | |
| Q2 2012 | +11.9% | — | — | |
| Q1 2012 | +11.0% | — | — | |
| Q4 2009 | -6.1% | — | — | |
| Q1 2010 | -6.1% | — | — | |
| Q3 2011 | -7.1% | — | — | |
| Q3 2010 | -7.1% | — | — | |
| Q4 2010 | -4.0% | — | — | |
| Q2 2010 | -4.0% | — | — | |
| Q2 2011 | -4.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro